Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of pyridoxal phosphate therapy in patients with primary hyperoxaluria type I
2009-015217-52Phase 2Completed
- Sponsor
- University of Cologne
- Start
- Feb 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pyridoxal-5'-phosphate in Primary Hyperoxaluria Type 1 (PH1) and vitamin B6 deficiency, sponsored by University of Cologne. Started Feb 2010; status: completed.
02
Drugs
pyridoxal-5'-phosphate
03
Conditions
Primary Hyperoxaluria Type 1 (PH1)vitamin B6 deficiency
Beyond the preview
Go deeper on 2009-015217-52.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015217-52.